Endometrial pipelle biopsy compared to conventional dilatation and curettage

  • S. Ong
  • T. Duffy
  • P. Lenehan
  • J. Murphy


Dilatation and curettage (D+C) is the most common operation performed in Britain. The liberal use of D+C has been criticised. The objective of this study was to evaluate the use of outpatient endometrial pipelle biopsy and determine its safety in terms of detecting abnormalities. Complications and financial costs were also evaluated. Data were reviewed from an active gynaecological unit from February 1993 to January 1995. A total of 303 D+Cs and 104 endometrial pipelle biopsies were performed in this period. Nine malignancies were detected by D+C and 1 by pipelle biopsy. A total of 24 and 3 benign abnormalities were detected by each method respectively. There was a higher complication rate in the D+C group but the failure rate was higher in the endometrial pipelle biopsy group. The monetary savings over this period is estimated at £20,307. There were no missed malignancies to our knowledge over the 8 yr period since endometrial pipelle biopsy was introduced to the hospital.


Endometrial Cancer Endometrial Carcinoma Endometrial Biopsy Endometrial Sampling Chronic Endometritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Coulter, A., Klassen, A., MacKenzie, I. Z., McPherson, K. Diagnostic dilatation and curettage: is it used appropriately? BMJ 1993; 306: 236–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Grimes, D. A. Diagnostic dilatation and curettage: A reappraisal. Am. J. Obset. Gynecol. 1982; 142: 1–6.Google Scholar
  3. 3.
    Crissman, J. D., Azoury, R. S., Barnes, A. E., Schellhas, H. F. Endometrial carcinoma in women 40 years of age or younger. Obstet. Gynecol. 1981; 57: 699–704.PubMedGoogle Scholar
  4. 4.
    Smith, J. J., Schulman, H. Current dilatation and curettage practice: A need for revision. Obstet. Gynecol. 1985; 65: 516–518.PubMedGoogle Scholar
  5. 5.
    Allen, D. G., Correy, J. F., Marsden, D. E. Abnormal uterine bleeding and cancer of the genital tract. Aust. NZ J. Obstet. Gynaecol. 1990; 30: 81–83.CrossRefGoogle Scholar
  6. 6.
    Hammond, R. H., Oppenheimer, L. W., Saunders, P. G. Diagnostic role of dilatation and curettage in the management of abnormal premenopausal bleeding. British J. Obstet. Gynaecol. 1989; 96: 496–500.Google Scholar
  7. 7.
    Mackenzie, I. Z., Bibby, J. G. Critical assessment of dilatation and curettage in 1029 women. The Lancet 1978; September: 566–568.Google Scholar
  8. 8.
    Cornier, E. The pipelle: A disposable device for endometrial biopsy. Am. J. Obstet. Gynecol. 1984: 109–110.Google Scholar
  9. 9.
    Stovall, T. G., Photopulos, G. J., Poston, W. M., Sandles, L. G. Pipelle endometrial sampling in patients with known endometrial carcinoma. Obstet. Gynecol, 1991; 77: 954–956.PubMedGoogle Scholar
  10. 10.
    Ferry, J., Farnsworth, A., Webster, M., Wren, B. The efficacy of the pipelle endometrial biopsy in detecting endometrial carcinoma. Aust. NZ J. Obstet. Gynaecol. 1993; 33(1): 76–78.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • S. Ong
    • 1
  • T. Duffy
    • 1
  • P. Lenehan
    • 1
  • J. Murphy
    • 1
  1. 1.St. Vincent’s Hospital, Elm ParkDublin 4

Personalised recommendations